Impaired corpus luteum function in ectopic pregnancy cannot be explained by altered human chorionic gonadotropin.

Area of Science:

• Reproductive Endocrinology
• Maternal-Fetal Medicine
• Steroid Biochemistry

Background:

• Ectopic pregnancy is associated with lower serum levels of progesterone, 17 beta-estradiol, and 17-hydroxyprogesterone.
• The precise cause of these reduced steroid levels in early pregnancy complications remains unclear.

Purpose of the Study:

• To investigate the cause of diminished serum steroid levels in women with ectopic pregnancy.
• To determine if altered human chorionic gonadotropin (hCG) bioactivity contributes to lower steroidogenesis.

Main Methods:

• Matched case-control study comparing women with ectopic pregnancy and normal intrauterine pregnancy.
• Serum steroid levels (progesterone, estradiol, 17-hydroxyprogesterone) and intact hCG levels were measured.
• hCG bioactivity was assessed using Leydig cell testosterone secretion and cAMP generation assays.

Main Results:

• Women with ectopic pregnancy exhibited significantly lower median levels of progesterone, estradiol, and 17-hydroxyprogesterone compared to controls.
• Ratios of intact hCG to hCG beta and serum hCG bioactivity were similar between ectopic and normal pregnancies.
• Serum hCG from both groups demonstrated comparable stimulation of cAMP generation in testicular cells.

Conclusions:

• Lower serum steroid levels in ectopic pregnancy are not attributable to altered hCG bioactivity.
• The findings suggest a potential primary defect in corpus luteum function or other unmeasured factors influencing ovarian steroid biosynthesis.